Heparin-Induced Thrombocytopenia

被引：5
作者：
Nicolaides, A.
Fareed, J.
Kakkar, A. K.
Comerota, A. J.
Goldhaber, S. Z.
Hull, R.
Myers, K.
Samama, M.
Fletcher, J.
Kalodiki, E.
Bergqvist, D.
Bonnar, J.
Caprini, J. A.
Carter, C.
Conard, J.
Eklof, B.
Elalamy, I.
Gerotziafas, G.
Geroulakos, G.
Giannoukas, A.
Greer, I.
Griffin, M.
Kakkos, S.
Lassen, M. R.
Lowe, G. D. O.
Markel, A.
Prandoni, P.
Raskob, G.
Spyropoulos, A. C.
Turpie, A. G.
Walenga, J. M.
Warwick, D.
机构：
来源：
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2013年 / 19卷 / 02期
关键词：
MOLECULAR-WEIGHT HEPARIN; PLATELET-AGGREGATION TEST; SEROTONIN-RELEASE ASSAY; CORONARY-ARTERY-BYPASS; OPTICAL-DENSITY VALUES; VENOUS LIMB GANGRENE; ARGATROBAN THERAPY; ANTIBODY-FORMATION; UNFRACTIONATED HEPARIN; HOSPITALIZED-PATIENTS;
D O I：
10.1177/1076029612474840s
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：208 / 214
页数：9
相关论文
共 117 条
[31]   Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia [J].
Gruel, Y ;
Pouplard, C ;
Nguyen, P ;
Borg, JY ;
Derlon, A ;
Juhan-Vague, I ;
Regnault, V ;
Samama, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) :786-792
[32]   Heparin-induced thrombocytopenia: Clinical considerations of alternative anticoagulation with various glycosaminoglycans and thrombin inhibitors [J].
Haas, S ;
Walenga, JM ;
Jeske, WP ;
Fareed, J .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1999, 5 (01) :52-59
[33]   Treatment options in heparin-induced thrombocytopenia [J].
Hook, Karen M. ;
Abrams, Charles S. .
CURRENT OPINION IN HEMATOLOGY, 2010, 17 (05) :424-431
[34]   The epitope specificity of heparin-induced thrombocytopenia [J].
Horsewood, P ;
Warkentin, TE ;
Hayward, CPM ;
Kelton, JG .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (01) :161-167
[35]   Argatroban anticoagulation in renal dysfunction: A literature analysis [J].
Hursting, Marcie J. ;
Murray, Patrick T. .
NEPHRON CLINICAL PRACTICE, 2008, 109 (02) :C80-C94
[36]   Reducing Harm Associated with Anticoagulation Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia [J].
Hursting, Marcie J. ;
Soffer, Joseph .
DRUG SAFETY, 2009, 32 (03) :203-218
[37]   Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia [J].
Hursting, MJ ;
Lewis, BE ;
Macfarlane, DE .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (03) :279-287
[38]   Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases [J].
Kadidal, VV ;
Mayo, DJ ;
Horne, MK .
JOURNAL OF INTERNAL MEDICINE, 1999, 246 (03) :325-329
[39]   Heparin-Induced Thrombocytopenia: A Serious Complication of Heparin Therapy for Acute Stroke [J].
Kawano, Hiroyuki ;
Toyoda, Kazunori ;
Miyata, Shigeki ;
Yamamoto, Haruko ;
Okamoto, Akira ;
Kakutani, Isami ;
Walenga, Jeanine M. ;
Naritomi, Hiroaki ;
Minematsu, Kazuo .
CEREBROVASCULAR DISEASES, 2008, 26 (06) :641-649
[40]   The management of heparin-induced thrombocytopenia [J].
Keeling, D ;
Davidson, S ;
Watson, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (03) :259-269
12345678910